World Health Organization (WHO) has officially prequalified a new vaccine designed to combat the mosquito-borne viral disease; dengue fever. The WHO announced a news release, that the new vaccine for ...

The vaccine, TAK-003, is the second dengue vaccine to be prequalified by WHO. WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission ...

A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it ...

The prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible for procurement by UN agencies including UNICEF. Photo: AFP A new ...

The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda ...

(MENAFN- Caribbean News Global) GENEVA, Switaerland – A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue ...

TAK-003 is the second dengue vaccine to be prequalified by WHO Geneva: The World Health Organization (WHO) said on Wednesday that it had prequalified Takeda Pharmaceuticals' dengue vaccine.

The new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO.

The World Health Organisation (WHO) this week pre-qualified a new vaccine for a mosquito-borne disease called –Dengue, which is mostly reported in the coastal part of Kenya. This is the first ever ...

KUALA LUMPUR - The World Health Organisation (WHO) prequalified a new dengue vaccine TAK-003 on May 10. TAK-003, developed by Takeda, is the second dengue vaccine to be prequalified by WHO. It is a ...